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BACKGROUND 
Allergic rhinitis is a common inflammatory disease prevalent world wide which is 
known to affect both olfaction and quality of life. Very little information is available 
regarding the impact of medical therapy on these parameters in patient with allergic 
rhinitis in the Indian subcontinent. 
OBJECTIVES 
        1)To assess the prevalence of olfactory dysfunction in patients diagnosed with   allergic 
rhinitis 
2)  To evaluate associated quality- of –life changes in patients diagnosed with allergic 
rhinitis 3) To assess the reversal of olfactory dysfunction and any change in quality –of-
life in affected patients following medical therapy 
METHODS 
A cross-sectional hospital based study was conducted  prospectively in patients 
diagnosed with allergic rhinitis All recruited patients underwent butanol threshold testing for 
assessment of olfactory function and assessment of quality of life using a RQLQ 
questionnaire. These patients underwent medical therapy with steroidal nasal spray, 
antihistamines and/ or leukotriene receptor antagonists for about 8-12 weeks 
At the end of therapy, the same tests were administered again. As there is no 
normative data for the Indian population, 40 normal individuals were tested to obtain 
normative data for olfaction testing. 
RESULTS 
A total of 150 patients with allergic rhinitis were recruited. Most patients 
(72%) had intermittent, mild or moderate allergic rhinitis. Smokers were more likely 
to have moderate to severe allergic rhinitis than non-smokers (p=0.01). The 
prevalence of hyposmia in patients with allergic rhinitis was 28.7%. The degree of 
hyposmia was mild (52.9%) or moderate (35.3%)in the majority. Following therapy, 
there was a significant improvement in olfaction scores (p=0.001). Quality of life 
(QOL)was affected in all patients with allergic rhinitis and the mean QOL scores were 
raised, particularly those affecting nasal, emotional and non-nasal symptoms. These 
scores also showed a significant improvement following therapy (p=0.00) 
CONCLUSION 
Allergic rhinitis impacts both olfaction and quality of life in Indian patients.  
The problem is more pronounced in smokers. With adequate medical therapy which 
includes a steroid nasal spray, antihistamine and leukotriene anatagonist, most patients 
find significant benefit both for olfaction as well as quality of life. 
 
